Staff

TOP 5 publications:

1. Kroll SL, Hulka LM, Kexel AK, Vonmoos M, Preller KH, Treyer V, Ametamey SM, Baumgartner MR, Boost C, Pahlisch F, Rohleder C, Leweke FM, Quednow BB. Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density.Transl Psychiatry. 2023 13(1):325.
2. Bouter Y, Brzózka MM, Rygula R, Pahlisch F, Leweke FM, Havemann-Reinecke U, Rohleder C. Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice.Cannabis Cannabinoid Res. 2020 5(1):51-61.
3. Couttas TA, Boost C, Pahlisch F, Sykorova EB, Mueller JK, Jieu B, Leweke JE, Dammann I, Hoffmann AE, Loeffler M, Grimm O, Enning F, Flor H, Meyer-Lindenberg A, Koethe D, Rohleder C, Leweke M. Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.BMJ Ment Health. 2024 27(1).
4. Rohleder C, Pahlisch F, Graf R, Endepols H, Leweke FM. Different pharmaceutical preparations of Δ -tetrahydrocannabinol differentially affect its behavioral effects in rats.Addict Biol. 2020 25(3):e12745, 1-10. Epub 2019 Apr 3.
5. Koethe D, Pahlisch F, Hellmich M, Rohleder C, Mueller JK, Meyer-Lindenberg A, Torrey EF, Piomelli D, Leweke FM. Familial Abnormalities of Endocannabinoid Signaling in Schizophrenia.World J Biol Psychiatry. 2019 20(2):117-125. Epub 2018 Mar 9.